Celgene Corp – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

17 Celgene Corp Expert Interviews, now on BamSEC.

Powered by Tegus.

Financials Filter

ended 09/30/19 Q3

ended 06/30/19 Q2

ended 03/31/19 Q1

ended 12/31/18 FY 2018 – amended

ended 12/31/18 FY 2018

Prospectuses and Registrations Filter

Securities registration termination

Post-effective amendment to details of business combination or exchange offer

Post-effective amendment to details of business combination or exchange offer

Post-effective amendment to details of business combination or exchange offer

Amendment to registration of securities for employees

Ownership Filter

Acceleron Pharma Inc

Acceleron Pharma Inc

Sutro Biopharma Inc

News Filter

Completion of Acquisition or Disposition of Assets, Material Modification to Rights of Security Holders, Financial Statements or Exhibits

Announces Plans to Transfer Listing of Celgene’s Contingent Value Rights Following Closing of Acquisition by Bristol-Myers Squibb

Reports Third Quarter 2019 Operating and Financial Results

Material Definitive Agreement, Financial Statements or Exhibits

Reports Second Quarter 2019 Operating and Financial Results

Proxies Filter

Proxy related to merger

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Other Filter

Correspondence with the SEC

No action letter

No action letter

Letter from the SEC

Correspondence with the SEC